Form 483

CMIC CMO USA Corporation Form 483, 2018-01-11

FDA issued a Form 483 to CMIC CMO USA Corporation on 2018-01-11 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

CMIC CMO USA Corporation · Cranbury, United States · Issued January 11, 2018

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

11 Jan 2018
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Tamil Arasu, Unnee Ranjan

11 Jan 2018
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Tamil Arasu, Unnee Ranjan

11 Jan 2018
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Tamil Arasu, Unnee Ranjan

11 Jan 2018
21 CFR 211.194(a)(4)

Complete Test Data

Cited by Tamil Arasu, Unnee Ranjan

11 Jan 2018
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Tamil Arasu, Unnee Ranjan

Inspected site

CCCMIC CMO USA CorporationCranbury, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere